Taiwan FDA registration 8c94e479436b1f60d9ba8924d6b5ee0d
VITROS Immunodiagnostic Products C-Peptide Reagent Pack (Non-Sterile)
TW: 維特司C胜肽免疫檢測試劑組(未滅菌)
Taiwan·Risk Class 1·MD·ORTHO-CLINICAL DIAGNOSTICS·Registered Oct 16, 2020 – Oct 16, 2025ExpiredRegistration details
- Analysis ID
- 8c94e479436b1f60d9ba8924d6b5ee0d
- License Form
- Ministry of Health Medical Device Import No. 022037
- Customs Code
- DHA09402203705
Company information
- Manufacturer
- ORTHO-CLINICAL DIAGNOSTICS
- Manufacturer Country
- United Kingdom
- Authorized Representative
- DKSH TAIWAN LTD.
Product details
- Intended Use
- Limited to the first level identification range of the insulin precursor C-peptide test system (A.1135) of the management method for medical devices.
- Product Type (Level 1)
- A Clinical chemistry and clinical toxicology
- Product Type (Level 2)
- A1135 Insulin Precursor C-Peptide Test System
- Import Information
- Imported from abroad
Dates and status
- Registration Date
- Oct 16, 2020
- Expiry Date
- Oct 16, 2025
About this record
Access comprehensive regulatory information for VITROS Immunodiagnostic Products C-Peptide Reagent Pack (Non-Sterile) in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 1 medical device is registered under number 8c94e479436b1f60d9ba8924d6b5ee0d and manufactured by ORTHO-CLINICAL DIAGNOSTICS. The authorized representative in Taiwan is DKSH TAIWAN LTD..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices